. Construction of pLV/Puro-EF1α-CCR2-T2A-dtomato.
(A) Construction of pLV/Puro-EF1α-CCR2-T2A-dtomato. The CCR2-encoding vector was constructed using the multisite gateway method previously described.
(B) Schematic diagram of the dtomato and CCR2 plasmid.
(C) The morphologies of MSC dtomato and MSC CCR2 were not found abnormal under the bright field microscopy and the red fluorescence was observed using the fluorescence microscopy. Scale bar:
150μm. (A) The expression of surface markers including CD29, CD34, CD44, CD45, CD73, CD90, CD105 and CD166 were detected by flow cytometry in both of MSC dtomato and MSC CCR2 .
(B) FACS-sorted dtomato + MSCs exhibited osteogenic and adipogenic differentiation capacity.
Scale bar: 150μm.
(C) Osteogenic and adipogenic markers of differentiated MSCs were analyzed by PCR. Six randomized fields were measured, and the experiments were performed in four replicates. All data are expressed as means ± SEM; *p<0.05 and n.s. is non-significant. (A-B) The interference efficiencies of shPRDX4-1 and shPRDX4-2 were determined by qRT-PCR (A) and western blotting (B). ShPRDX4-2 appeared to be more efficient than shPRDX4-1. n=4.
All data are expressed as means ± SEM; *p<0.05 and ***p<0.001. n=7. All data are expressed as means ± SEM; *p<0.05 and n.s. is non-significant. 
